X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5701) 5701
humans (5280) 5280
life sciences & biomedicine (5171) 5171
cell cycle (3106) 3106
g1 phase - drug effects (2765) 2765
animals (2701) 2701
apoptosis (2568) 2568
g1 phase (2520) 2520
cell line, tumor (2488) 2488
apoptosis - drug effects (2159) 2159
oncology (2086) 2086
cell proliferation - drug effects (1753) 1753
cell biology (1617) 1617
mice (1605) 1605
cell proliferation (1333) 1333
flow cytometry (1328) 1328
biochemistry & molecular biology (1259) 1259
cell cycle - drug effects (1230) 1230
cancer (1205) 1205
proteins (1192) 1192
antineoplastic agents - pharmacology (1189) 1189
female (1160) 1160
g1 phase cell cycle checkpoints - drug effects (1122) 1122
phosphorylation (938) 938
male (879) 879
kinases (858) 858
gene expression (841) 841
cell growth (838) 838
signal transduction (814) 814
dose-response relationship, drug (800) 800
tumor cells, cultured (791) 791
cell division - drug effects (783) 783
signal transduction - drug effects (719) 719
cell survival - drug effects (712) 712
cells, cultured (691) 691
pharmacology & pharmacy (686) 686
cell line (681) 681
s phase - drug effects (635) 635
analysis (634) 634
research (631) 631
g1 phase - physiology (610) 610
research article (596) 596
resting phase, cell cycle - drug effects (584) 584
rats (572) 572
blotting, western (566) 566
time factors (552) 552
tumors (541) 541
s phase (535) 535
science & technology - other topics (511) 511
tumor suppressor protein p53 - metabolism (504) 504
multidisciplinary sciences (501) 501
breast cancer (484) 484
medicine, research & experimental (482) 482
research & experimental medicine (482) 482
cyclin-dependent kinase inhibitor p21 (475) 475
cancer therapies (474) 474
cytotoxicity (473) 473
medicine (458) 458
transfection (446) 446
cyclins - metabolism (440) 440
dna damage (434) 434
health aspects (430) 430
biology (429) 429
chemotherapy (429) 429
cell cycle proteins - metabolism (426) 426
cyclin d1 - metabolism (420) 420
cyclin d1 (414) 414
phosphorylation - drug effects (414) 414
retinoblastoma protein - metabolism (408) 408
g1 phase - genetics (406) 406
mice, nude (401) 401
deoxyribonucleic acid--dna (396) 396
care and treatment (391) 391
cyclin-dependent kinases - metabolism (386) 386
genetic aspects (386) 386
science (383) 383
enzyme inhibitors - pharmacology (380) 380
gene expression regulation, neoplastic - drug effects (380) 380
cell death (376) 376
cyclin-dependent kinase inhibitor p27 (363) 363
cell division (358) 358
studies (347) 347
xenograft model antitumor assays (345) 345
gene expression regulation, neoplastic (343) 343
cyclin-dependent kinase 2 (341) 341
rna interference (341) 341
cell cycle checkpoints - drug effects (339) 339
cyclin-dependent kinase inhibitor p21 - metabolism (336) 336
proliferation (336) 336
protein-serine-threonine kinases - metabolism (331) 331
rna, messenger - metabolism (330) 330
cell cycle - physiology (327) 327
mice, inbred balb c (319) 319
reactive oxygen species - metabolism (319) 319
caspase (317) 317
proto-oncogene proteins c-akt - metabolism (317) 317
cyclin-dependent kinase 4 (316) 316
genetics & heredity (310) 310
metastasis (299) 299
physiological aspects (299) 299
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7400) 7400
Japanese (66) 66
Chinese (57) 57
Russian (14) 14
German (6) 6
French (3) 3
Portuguese (3) 3
Norwegian (2) 2
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 11/2007, Volume 34, Issue 11, pp. 1109 - 1115
...) by anti-apoptotic effects. Resveratrol, a polyphenolic phytoalexin extracted from grapes and wine, has been reported to act as an oestrogen receptor agonist... 
coronary artery disease | vasculogenesis | resveratrol | endothelial progenitor cells | Vasculogenesis | Coronary artery disease | Endothelial progenitor cells | Resveratrol | Pharmacology & Pharmacy | Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Survival - drug effects | Neovascularization, Physiologic - drug effects | Endothelial Cells - metabolism | Humans | Cells, Cultured | Vascular Endothelial Growth Factor A - metabolism | G1 Phase - drug effects | Stilbenes - pharmacology | Cell Adhesion - drug effects | Stem Cells - metabolism | Dose-Response Relationship, Drug | Cell Movement - drug effects | Time Factors | Cell Differentiation - drug effects | Stem Cells - drug effects | Resting Phase, Cell Cycle - drug effects | Cell Proliferation - drug effects | S Phase - drug effects | Phytoestrogens - pharmacology | Endothelial Cells - drug effects | Cell Survival, drug effects | G1 Phase, drug effects | Vascular Endothelial Growth Factor A, metabolism | Cell Proliferation, drug effects | Cell Adhesion, drug effects | Stem Cells, metabolism | Endothelial Cells, metabolism | Phytoestrogens, pharmacology | S Phase, drug effects | Endothelial Cells, drug effects | Cell Movement, drug effects | Cell Differentiation, drug effects | Neovascularization, Physiologic, drug effects | G0 Phase, drug effects | Stilbenes, pharmacology | Stem Cells, drug effects | Endothelial growth factors | Analysis | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 03/2008, Volume 105, Issue 12, pp. 4826 - 4831
To enhance therapeutic efficacy and reduce adverse effects, practitioners of traditional Chinese medicine (TCM... 
Up regulation | Acute promyelocytic leukemia | Arsenic | Medical treatment | Leukemia | Cell cycle | Cell lines | Mice | Cellular differentiation | Blood | Traditional Chinese medicine | Active ingredient | Systems biology | Synergism | Tetraarsenic tetrasulfide | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Transcription, Genetic - drug effects | Oncogene Proteins, Fusion - metabolism | Leukemia, Promyelocytic, Acute - pathology | Humans | Drugs, Chinese Herbal - pharmacology | G1 Phase - drug effects | Aquaporins - genetics | Arsenicals - therapeutic use | Ubiquitination - drug effects | Protein Processing, Post-Translational - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Drugs, Chinese Herbal - therapeutic use | Disease Models, Animal | Sulfides - pharmacology | Medicine, Chinese Traditional | Arsenicals - pharmacology | Aquaporins - metabolism | Sulfides - therapeutic use | Drug Synergism | Up-Regulation - drug effects | Animals | Cell Differentiation - drug effects | Cell Line, Tumor | Resting Phase, Cell Cycle - drug effects | Leukemia, Promyelocytic, Acute - genetics | Leukemia, Promyelocytic, Acute - drug therapy | Evaluation | Medicine, Chinese | Research | Drug synergism | Index Medicus | systems biology | synergism | Biological Sciences | traditional chinese medicine | active ingredient | tetraarsenic tetrasulfide
Journal Article
PloS one, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, pp. e0158963 - e0158963
...) and other Middle Eastern countries. Ajwa date has been described in the traditional and alternative medicine to provide several health benefits including anticholesteremic, antioxidant, hepatoprotective and anticancer effects... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Adenocarcinoma - pathology | Apoptosis - drug effects | Microscopy, Phase-Contrast | Plant Extracts - pharmacology | Humans | Caspase 3 - metabolism | Apoptosis - genetics | Membrane Potential, Mitochondrial - drug effects | Neoplasm Proteins - metabolism | MCF-7 Cells | Cell Cycle Checkpoints - genetics | Female | Adenocarcinoma - genetics | DNA Fragmentation - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Real-Time Polymerase Chain Reaction | Methanol | In Situ Nick-End Labeling | Up-Regulation - genetics | Cell Shape - drug effects | Up-Regulation - drug effects | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Cell Cycle Checkpoints - drug effects | Cell Proliferation - drug effects | S Phase - drug effects | Phoeniceae - chemistry | Adenocarcinoma | Cell culture | Patient outcomes | Date palm | Breast cancer | Research | Antineoplastic agents | Gene expression | Statistics | Date | Antimitotic agents | Analysis | Health aspects | Apoptosis | Cytochrome | Cell proliferation | Flow cytometry | Bax protein | Bcl-2 protein | p53 Protein | Cytology | Indigenous plants | Biochemistry | Kinases | Cancer therapies | Cell morphology | Anticancer properties | Antioxidants | Mitochondria | Cell growth | Precision medicine | Cell cycle | Polyphenols | Membrane potential | Medical research | Statistical analysis | Caspase | Shrinkage | Flavonoids | Phytochemicals | FasL protein | Microscopy | Phase contrast | Alternative medicine | Annexin V | Synergistic effect | In vitro methods and tests | Prostate cancer | Index Medicus
Journal Article
Journal Article
Nature (London), ISSN 1476-4687, 01/2010, Volume 463, Issue 7277, pp. 113 - 117
.... At least two cell cycle-regulated protein kinase systems, the S-phase-specific cyclin-dependent protein kinases (S-CDKs... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hydroxyurea - pharmacology | Protein-Serine-Threonine Kinases - deficiency | Sequence Deletion | Phosphorylation | Substrate Specificity | G1 Phase - drug effects | Minichromosome Maintenance Complex Component 4 | Cell Cycle Proteins - antagonists & inhibitors | Cell Cycle Proteins - chemistry | DNA-Binding Proteins - metabolism | Saccharomyces cerevisiae - metabolism | Cell Cycle Proteins - genetics | Protein-Serine-Threonine Kinases - metabolism | Protein Structure, Tertiary | DNA-Binding Proteins - antagonists & inhibitors | Microbial Viability - drug effects | Saccharomyces cerevisiae Proteins - antagonists & inhibitors | Cell Cycle Proteins - metabolism | Protein-Serine-Threonine Kinases - genetics | Saccharomyces cerevisiae Proteins - genetics | DNA-Binding Proteins - genetics | DNA-Binding Proteins - chemistry | Genes, Essential | Saccharomyces cerevisiae - cytology | Saccharomyces cerevisiae Proteins - metabolism | S Phase - physiology | Saccharomyces cerevisiae - enzymology | Cell Proliferation - drug effects | S Phase - drug effects | DNA Damage | Saccharomyces cerevisiae - growth & development | Saccharomyces cerevisiae Proteins - chemistry | DNA replication | Interphase | Analysis | Physiological aspects | Genetic aspects | Research | Biological control systems | Protein kinases | Proteins | Cell division | Kinases | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, pp. e0120334 - e0120334
...) phase... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gene Expression Regulation, Enzymologic - drug effects | Humans | Myeloid Cell Leukemia Sequence 1 Protein - metabolism | G1 Phase - drug effects | DNA-Directed DNA Polymerase - genetics | Proto-Oncogene Proteins c-bcl-2 - metabolism | Female | G1 Phase - genetics | Gene Expression Regulation, Neoplastic - drug effects | bcl-2-Associated X Protein - genetics | DNA-Directed DNA Polymerase - biosynthesis | Uterine Cervical Neoplasms - enzymology | bcl-2-Associated X Protein - metabolism | Uterine Cervical Neoplasms - drug therapy | Cisplatin - pharmacology | DNA-Binding Proteins - genetics | Uterine Cervical Neoplasms - genetics | S Phase - genetics | Myeloid Cell Leukemia Sequence 1 Protein - genetics | Drug Resistance, Neoplasm - genetics | S Phase - drug effects | HeLa Cells | DNA-Binding Proteins - biosynthesis | Proto-Oncogene Proteins c-bcl-2 - genetics | Drug Resistance, Neoplasm - drug effects | Proteins | Immunohistochemistry | Care and treatment | DNA damage | Cancer cells | Lymphomas | Cervical cancer | Cancer | Cell proliferation | Bax protein | DNA polymerase | Bcl-2 protein | Leukemia | Lung cancer | Oncology | Genomes | Paraffin | Drug resistance | Tissues | DNA repair | Phase transitions | Damage tolerance | Bcl-x protein | Catalysis | Deoxyribonucleic acid--DNA | G1 phase | Medical research | Colonies | Gynecology | Breast cancer | Tumor cell lines | Cervix | Obstetrics | Lymphoma | Immunological tolerance | Cisplatin | Mcl-1 protein | Mutagenesis | Lymphocytes B | S phase | Medical prognosis | Li Yang | Sensitivity enhancement | DNA-directed DNA polymerase | Apoptosis | B-cell lymphoma | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Cell cycle (Georgetown, Tex.), ISSN 1551-4005, 10/2014, Volume 6, Issue 3, pp. 318 - 329
Journal Article
10.